Alpha Family Trust’s Gilead Sciences GILD Stock Holding History

Alpha Family Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Hold	8,605	–	–	0.44%	34
2026 Q1	$1.2M	Hold	8,605	–	–	0.58%	29
2025 Q4	$1.06M	Hold	8,605	–	–	0.48%	33
2025 Q3	$955K	Hold	8,605	–	–	0.45%	40
2025 Q2	$954K	Hold	8,605	–	–	0.47%	38
2025 Q1	$964K	Hold	8,605	–	–	0.56%	35
2024 Q4	$795K	Hold	8,605	–	–	0.45%	34
2024 Q3	$721K	Sell	8,605 -710	-8%	-$54.2K	0.4%	44
2024 Q2	$639K	Buy	9,315 +2,060	+28%	+$137K	0.37%	50
2024 Q1	$531K	Buy	7,255 +710	+11%	+$54.6K	0.32%	59
2023 Q4	$530K	Hold	6,545	–	–	0.36%	51
2023 Q3	$490K	Hold	6,545	–	–	0.37%	53
2023 Q2	$504K	Sell	6,545 -1,670	-20%	-$133K	0.35%	47
2023 Q1	$682K	Buy	8,215 +780	+10%	+$64.6K	0.54%	34
2022 Q4	$638K	Buy	+7,435	New	+$589K	0.58%	35

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alpha Family Trust's GILD Position: Q2 2026 in Review

Alpha Family Trust held its Gilead Sciences (GILD) position steady in Q2 2026 at 8,605 shares worth $1.09M. The position accounts for 0.44% of the portfolio, ranked #34.

Alpha Family Trust first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.2M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Alpha Family Trust held 8,605 shares of Gilead Sciences worth $1.09M as of Q2 2026.
Alpha Family Trust left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.44% of Alpha Family Trust's portfolio in Q2 2026, its #34 holding.
Alpha Family Trust first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
Alpha Family Trust's Gilead Sciences position peaked at $1.2M in Q1 2026.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alpha Family Trust's 13F filing for Q2 2026, filed 10 Aug 2026.